[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:agxt-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"AGXT Gene",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06839235","Phase 1\u002F2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:46.653867Z","2026-05-05T02:43:29.220896Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT02026388","Rare Kidney Stone Consortium Biobank",[],"2026-08-26T02:18:38.865010Z","2026-05-13T02:55:06.081438Z",{"nct_id":23,"title":24,"phases":25,"status":26,"updated_at":27,"content_modified":28},"NCT04430426","Heterozygous Individuals for AGXT and Kidney Stones",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:43.339060Z","2026-07-24T01:27:14.900136Z"]